BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gunn D, Garsed K, Lam C, Singh G, Lingaya M, Wahl V, Niesler B, Henry A, Hall IP, Whorwell P, Spiller R. Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron. Aliment Pharmacol Ther. 2019;50:538-546. [PMID: 31342534 DOI: 10.1111/apt.15420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Shen J, Zhang B, Chen J, Cheng J, Wang J, Zheng X, Lan Y, Zhang X. SAHA Alleviates Diarrhea-Predominant Irritable Bowel Syndrome Through Regulation of the p-STAT3/SERT/5-HT Signaling Pathway. JIR 2022;Volume 15:1745-56. [DOI: 10.2147/jir.s331303] [Reference Citation Analysis]
2 Gunn D, Garsed K, Lam C, Singh G, Lingaya M, Wahl V, Niesler B, Henry A, Hall I, Whorwell P, Spiller R. Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer? Authors' reply. Aliment Pharmacol Ther 2019;50:826-7. [PMID: 31532555 DOI: 10.1111/apt.15465] [Reference Citation Analysis]
3 Vahora IS, Tsouklidis N, Kumar R, Soni R, Khan S. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome. Cureus 2020;12:e9871. [PMID: 32968548 DOI: 10.7759/cureus.9871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Burns GL, Hoedt EC, Walker MM, Talley NJ, Keely S. Physiological mechanisms of unexplained (functional) gastrointestinal disorders. J Physiol 2021. [PMID: 34705270 DOI: 10.1113/JP281620] [Reference Citation Analysis]
5 Rokkas T, Ekmektzoglou K, Niv Y. Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies. Ann Gastroenterol 2021;34:535-46. [PMID: 34276193 DOI: 10.20524/aog.2021.0619] [Reference Citation Analysis]
6 Zhang C, Shao H, Li D, Xiao N, Tan Z. Role of tryptophan-metabolizing microbiota in mice diarrhea caused by Folium sennae extracts. BMC Microbiol 2020;20:185. [PMID: 32600333 DOI: 10.1186/s12866-020-01864-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chen M, Ruan G, Chen L, Ying S, Li G, Xu F, Xiao Z, Tian Y, Lv L, Ping Y, Cheng Y, Wei Y. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Front Endocrinol 2022;13:817100. [DOI: 10.3389/fendo.2022.817100] [Reference Citation Analysis]
8 Colomier E, Algera J, Melchior C. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front Pharmacol 2020;11:629026. [PMID: 33679391 DOI: 10.3389/fphar.2020.629026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shi K, Qu L, Lin X, Xie Y, Tu J, Liu X, Zhou Z, Cao G, Li S, Liu Y. Deep-Fried Atractylodis Rhizoma Protects against Spleen Deficiency-Induced Diarrhea through Regulating Intestinal Inflammatory Response and Gut Microbiota. Int J Mol Sci 2019;21:E124. [PMID: 31878055 DOI: 10.3390/ijms21010124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Irving H, Turek I, Kettle C, Yaakob N. Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses. Int J Mol Sci 2021;22:11910. [PMID: 34769340 DOI: 10.3390/ijms222111910] [Reference Citation Analysis]
11 Roberts A, Grafton G, Powell AD, Brock K, Chen C, Xie D, Huang J, Liu S, Cooper AJ, Brady CA, Qureshi O, Stamataki Z, Manning DD, Moore NA, Sargent BJ, Guzzo PR, Barnes NM. CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome. J Pharmacol Exp Ther 2020;373:122-34. [PMID: 32102919 DOI: 10.1124/jpet.119.261008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Gunn D, Garsed K, Lam C, Singh G, Lingaya M, Wahl V, Niesler B, Henry A, Hall IP, Whorwell P, Spiller R. Abnormalities of mucosal serotonin metabolism and 5-HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron. Aliment Pharmacol Ther. 2019;50:538-546. [PMID: 31342534 DOI: 10.1111/apt.15420] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
13 Eliasen A, Kornholt J, Mathiasen R, Wadt K, Stoltze U, Brok J, Rechnitzer C, Schmiegelow K, Dalhoff K. Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study. Pharmacogenet Genomics 2022;32:72-8. [PMID: 34750329 DOI: 10.1097/FPC.0000000000000460] [Reference Citation Analysis]
14 Melchior C, Simrén M. Positive Effect of Bimodal Release Ondansetron in Irritable Bowel Syndrome With Diarrhea: Relevance of Low-Grade Inflammation? Am J Gastroenterol 2020;115:1976-8. [PMID: 33079746 DOI: 10.14309/ajg.0000000000001022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Van den Houte K, Colomier E, Schol J, Carbone F, Tack J. Recent advances in diagnosis and management of irritable bowel syndrome. Curr Opin Psychiatry 2020;33:460-6. [PMID: 32639360 DOI: 10.1097/YCO.0000000000000628] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu D, Ruan M, Tong C, Huang R, Tang M. Effect of Shugan Jianpi Recipe Combined with Cross Moxibustion on Biochemical Examination Indexes and Total Score of TCM Symptoms in Patients with Spleen-Stomach Damp-Heat Diarrhea Irritable Bowel Syndrome. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/8286146] [Reference Citation Analysis]
17 Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J Clin Med 2021;10:3429. [PMID: 34362210 DOI: 10.3390/jcm10153429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Abad IP, Fam RL, Nguyen D, Nowell CJ, Trinh PN, Manallack DT, Freihat LA, Chakrabarti J, Jamil A, Exintaris B, Yaakob NS, Irving HR. Visualising functional 5-HT3 receptors containing A and C subunits at or near the cell surface. Biomedicine & Pharmacotherapy 2020;132:110860. [DOI: 10.1016/j.biopha.2020.110860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Black CJ, Ford AC, Houghton LA. Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer? Aliment Pharmacol Ther 2019;50:825-6. [PMID: 31532550 DOI: 10.1111/apt.15455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Li Y, Li ZX, Xie CY, Fan J, Lv J, Xu XJ, Lv J, Kuai WT, Jia YT. Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota. World J Gastroenterol 2020; 26(48): 7633-7651 [PMID: 33505141 DOI: 10.3748/wjg.v26.i48.7633] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]